Login
 Forum
 
 
Personal data sheet
 Print preview
personal data approved: 2017. III. 04.
Personal data
name Eszter Ostorházi
year of birth 1971
name of institution
doctoral school
SE Doctoral School of Clinical Medicine (Supervisor)
accreditation statement submitted to: Semmelweis University, Budapest
Contact details
E-mail address droesztergmail.com
phone number +36 20 663-2339
Academic title
scientific degree, title Ph.D.
year degree was obtained 2012
discipline to which degree belongs clinical medicine
institution granting the degree Semmelweis University
Employment
1997 - Semmelweis University, Budapest
other (not specified) (egyetemi adjunktus)
Thesis topic supervisor
number of doctoral students supervised until now 1
number of students who fulfilled course requirements 0
students who obtained their degrees:
present PhD students:
Bálint Gergely Szabó (PhD) (2021/08)  DSCM-SE
Alexandra Brunner (PhD) (2018/08)  DSCM-SE
  Thesis topic proposals
Research
research area Microbiology
research field in which current research is conducted clinical medicine
Publications
2016

Schmidt R, Ostorhazi E, Wende E, Knappe D, Hoffmann R: Pharmacokinetics and in vivo efficacy of optimized oncocin derivatives., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 71: (4) pp. 1003-1011.
type of document: Journal paper/Article
language: English
DOI 
2016

Brunner A, Nemes-Nikodem E, Jeney C, Szabo D, Marschalko M, Karpati S, Ostorhazi E: Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary, ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS 15: (1) Paper 53. 6 p.
type of document: Journal paper/Article
language: English
DOI 
2015

Otvos L Jr, Ostorhazi E: Therapeutic utility of antibacterial peptides in wound healing., EXPERT REVIEW OF ANTI-INFECTIVE THERAPY 13: (7) pp. 871-881.
type of document: Journal paper/Article
language: English
DOI 
2014

Otvos L, Flick-Smith H, Fox M, Ostorhazi E, Dawson RM, Wade JD: The Designer Proline-rich Antibacterial Peptide A3-APO Prevents Bacillus anthracis Mortality by Deactivating Bacterial Toxins, PROTEIN AND PEPTIDE LETTERS 21: (4) pp. 374-381.
type of document: Journal paper/Article
number of independent citations: 3
language: English
DOI 
2013

Ostorhazi E, Voros E, Nemes-Nikodem E, Pinter D, Sillo P, Mayer B, Wade JD, Otvos L: Rapid systemic and local treatments with the antibacterial peptide dimer A3-APO and its monomeric metabolite eliminate bacteria and reduce inflammation in intradermal lesions infected with Propionibacterium acnes and meticillin-resistant Staphylococcus aureus, INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 42: (6) pp. 537-543.
type of document: Journal paper/Article
number of independent citations: 4
language: English
DOI 
2011

Ostorhazi E, Rozgonyi F, Szabo D, Binas A, Cassone M, Wade JD, Nolte O, Bethel CR, Bonomo RA, Otvos L Jr: Intramuscularly adminsistered peptide A3-APO is effective against carbapenem-resistant acinetobacter baumannii in mouse models of systemic infections, BIOPOLYMERS 96: (2) pp. 126-129.
type of document: Journal paper/Article
number of independent citations: 7
language: English
DOI 
2011

Ostorhazi E, Holub MC, Rozgonyi F, Harmos F, Cassone M, Wade JD, Otvos L: Broad-spectrum antimicrobial efficacy of peptide A3-APO in mouse models of multidrug-resistant wound and lung infections cannot be explained by in vitro activity against the pathogens involved, INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 37: (5) pp. 480-484.
type of document: Journal paper/Article
number of independent citations: 20
language: English
DOI 
2010

Szabo D, Ostorhazi E, Binas A, Rozgonyi F, Kocsis B, Cassone M, Wade JD, Nolte O, Otvos L Jr: The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models., INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 35: (4) pp. 357-361.
type of document: Journal paper/Article
number of independent citations: 27
language: English
DOI 
2010

Ostorhazi E, Rozgonyi F, Sztodola A, Harmos F, Kovalszky I, Szabo D, Knappe D, Hoffmann R, Cassone M, Wade JD, Bonomo RA, Otvos L Jr: Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 65: (11) pp. 2416-2422.
type of document: Journal paper/Article
number of independent citations: 14
language: English
Full text 
2009

Rozgonyi F, Szabo D, Kocsis B, Ostorhazi E, Abbadessa G, Cassone M, Wade JD, Otvos L Jr: The antibacterial effect of a proline-rich antibacterial peptide A3-APO, CURRENT MEDICINAL CHEMISTRY 16: (30) pp. 3996-4002.
type of document: Journal paper/Review paper
number of independent citations: 17
language: English
DOI 
Number of independent citations to these publications:92 
Scientometric data
list of publications and citations
number of scientific publications that meet accreditation criteria:
47
number of scientific publications:
63
monographs and professional books:
0
monographs/books in which chapters/sections were contributed:
0 
number of independent citations to scientific publications and creative works:
221


2017. XI. 23.
ODT ülés
Az ODT következő ülésére 2017. december 8-án 10.00 órakor kerül sor a Semmelweis Egyetem II. Belgyógyászati Klinika tetőterében levő MSD teremben (Bp. Szentkirályi u. 46., a rektori épület mellett).

 
All rights reserved © 2007, Hungarian Doctoral Council. Doctoral Council registration number at commissioner for data protection: 02003/0001. Program version: 2.2358 ( 2017. X. 31. )